AI-driven virtual mental health startup Siggy launches with $6 million seed

Key takeaways

• Siggy raised $6 million in pre-seed capital from Village Global and angel investors to build a continuous, AI-enabled mental-health system.
• The platform offers free, anonymous AI intake, a “Siggy Score” from wearable data, and monthly clinician visits, with coverage from all major commercial payers, Medicaid, Medicare, TRICARE and free access for veterans.
• Siggy plans to expand analytics to diagnose conditions such as diabetes or ALS and to supply neural-dataset services for clinical trials.

Siggy’s launch proves that a fully AI-enhanced mental-health pathway can be built without upfront patient fees. The startup raised $6 million in pre-seed funding and is now delivering a free, anonymous AI intake that feeds a persistent digital profile used for continuous care.

Fierce Healthcare reported that patients start with a chat-based conversation that requires no account or login. The AI records the full history, so when a human clinician joins the care loop, the patient never repeats prior details. An AI-generated provisional diagnosis is reviewed by clinicians before treatment options are offered. If a patient accepts, they see a human provider monthly while retaining the option to interact with the AI between visits.

The AI does not answer medical questions; instead, it redirects those queries to a licensed clinician. Its role is to remind patients of therapeutic exercises, serve as a sounding board, and flag higher-acuity needs to humans. Safety protocols automatically trigger alerts when patterns suggest a worsening condition.

Siggy also integrates wearable data to produce a daily “Siggy Score” out of 100, summarizing sleep quality, mood, bodily sensations and medication side effects. Weekly check-ins during the first two months enable clinicians to adjust doses or change medications based on observed trends. The platform can prescribe medications except for controlled substances, and clinicians taper patients off drugs when appropriate.

Coverage is extensive. Siggy is accepted by Blue Cross Blue Shield, Aetna, UnitedHealthcare, Humana, Medicaid, Medicare, TRICARE and is free for veterans. “Prescriptions aren’t the problem … it really is a fragmented system where you don’t have therapists ever speaking with your prescriber,” co-founder Jonathan Sabbagh told Fierce Healthcare.

Long-term ambitions extend beyond depression and anxiety. Siggy’s chief medical officer, Daniel Montville, M.D., envisions using speech analytics, lab results, genetic testing and biomarkers to identify diseases such as diabetes or ALS. The company also aims to build neural datasets to support clinical-trial recruitment for emerging technologies like brain implants.

For leaders evaluating digital-mental-health investments, Siggy’s model offers three immediate actions:

1. Pilot the free AI intake to capture patient histories without friction. The trade-off is reliance on algorithmic triage, requiring robust oversight to avoid missed high-risk cases.
2. Integrate wearable data streams to generate a composite health score. This provides granular daily insights but adds data-privacy compliance overhead and may increase device-related costs.
3. Align reimbursement strategies with payers that already cover virtual mental-health services, using Siggy’s existing payer network. This accelerates revenue capture but may limit flexibility if payer contracts change.

By balancing these steps, organizations can adopt continuous, AI-augmented mental-health care while managing risk, cost and regulatory responsibilities.